NEO Stock: Price, Earnings History and SEC Filings
NeoGenomics, Inc. (NEO) last traded at $17.38, down 3.07% on the latest session and down 5.3% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $0.01 against an analyst estimate of $-0.01, a beat of 200.0%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
NEO earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 28, 2026 | $0.01 | $-0.01 | +200.00% |
| Jun 2026 | Jul 28, 2026 | $-0.01 | $-0.06 | +83.33% |
| Mar 2026 | Apr 28, 2026 | $-0.06 | $-0.08 | +25.00% |
| Dec 2025 | Feb 17, 2026 | $0.00 | $-0.05 | +100.00% |
NEO beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How NEO reacts to earnings
Across its last 8 earnings releases, NEO moved 6.9% on average the next session, in either direction. It rose after 2 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-28 | After close | -0.33% |
| 2026-10-05 | After close | -13.70% |
| 2026-07-28 | After close | +13.96% |
| 2026-04-28 | After close | -0.67% |
| 2026-02-17 | Before open | +0.53% |
| 2026-01-12 | Before open | -5.09% |
| 2025-10-28 | Before open | -2.36% |
| 2025-07-29 | Before open | -18.73% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
NEO financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $727M | -$108M | -$22M | -14.9% | – |
| 2024 | $661M | -$79M | -$34M | -11.9% | – |
| 2023 | $592M | -$88M | -$31M | -14.9% | – |
| 2022 | $510M | -$144M | -$97M | -28.3% | – |
| 2021 | $484M | -$8M | -$91M | -1.7% | – |
| 2020 | $444M | $4M | -$28M | 0.9% | – |
| 2019 | $409M | $8M | $3M | 2.0% | – |
| 2018 | $277M | $3M | $30M | 1.0% | – |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for NEO
- 10-Q · Oct 28, 2026
- 8-K · Oct 28, 2026Results of operations, Financial statements and exhibits
- 8-K · Oct 5, 2026Results of operations, Officer or director change, Bylaw change
- 8-K · Aug 11, 2026Officer or director change
- 10-Q · Jul 28, 2026
- 8-K · Jul 28, 2026Results of operations, Financial statements and exhibits
- 8-K · Jul 20, 2026Regulation FD disclosure, Other events, Financial statements and exhibits
- 8-K · Jun 25, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Jun 22, 2026Material agreement, New financial obligation, Unregistered share sale
- 8-K · Jun 17, 2026Other events, Financial statements and exhibits
Insider filing activity
NEO insiders filed 4 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
NEO news
- 5 revealing analyst questions from NeoGenomics’s Q3 earnings callOct 31, 2026 · finance.yahoo.com
- NeoGenomics (NEO) Beat Q3 Expectations, Is The Stock Still Cheap?Oct 29, 2026 · finance.yahoo.com
- What NeoGenomics (NEO) Said on Its Q3 Earnings CallOct 29, 2026 · marketbeat.com
- NeoGenomics (NEO) Q3 2026 Earnings Call TranscriptOct 29, 2026 · fool.com
- NeoGenomics (NEO) Q3 Earnings and Revenues Beat EstimatesOct 28, 2026 · finance.yahoo.com
- NeoGenomics: Q3 Earnings SnapshotOct 28, 2026 · finance.yahoo.com
- NeoGenomics’s (NASDAQ:NEO) Q3 2026 sales beat estimatesOct 28, 2026 · finance.yahoo.com
- NeoGenomics Reports Third Quarter 2026 ResultsOct 28, 2026 · finance.yahoo.com
About NeoGenomics, Inc.
NeoGenomics, Inc. (NEO) is a US-listed public company on Nasdaq. The SEC classifies its business as Services-testing Laboratories. It is incorporated in N.V.. Its fiscal year ends in December.